全文获取类型
收费全文 | 14080篇 |
免费 | 839篇 |
国内免费 | 41篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 458篇 |
妇产科学 | 417篇 |
基础医学 | 2625篇 |
口腔科学 | 314篇 |
临床医学 | 1087篇 |
内科学 | 2644篇 |
皮肤病学 | 336篇 |
神经病学 | 1379篇 |
特种医学 | 622篇 |
外国民族医学 | 1篇 |
外科学 | 1704篇 |
综合类 | 112篇 |
一般理论 | 7篇 |
预防医学 | 699篇 |
眼科学 | 184篇 |
药学 | 963篇 |
中国医学 | 21篇 |
肿瘤学 | 1309篇 |
出版年
2023年 | 68篇 |
2022年 | 138篇 |
2021年 | 278篇 |
2020年 | 203篇 |
2019年 | 292篇 |
2018年 | 344篇 |
2017年 | 229篇 |
2016年 | 341篇 |
2015年 | 364篇 |
2014年 | 472篇 |
2013年 | 619篇 |
2012年 | 945篇 |
2011年 | 972篇 |
2010年 | 553篇 |
2009年 | 530篇 |
2008年 | 880篇 |
2007年 | 920篇 |
2006年 | 881篇 |
2005年 | 847篇 |
2004年 | 774篇 |
2003年 | 694篇 |
2002年 | 619篇 |
2001年 | 207篇 |
2000年 | 213篇 |
1999年 | 197篇 |
1998年 | 151篇 |
1997年 | 104篇 |
1996年 | 111篇 |
1995年 | 91篇 |
1994年 | 78篇 |
1993年 | 72篇 |
1992年 | 89篇 |
1991年 | 93篇 |
1990年 | 105篇 |
1989年 | 128篇 |
1988年 | 87篇 |
1987年 | 88篇 |
1986年 | 88篇 |
1985年 | 96篇 |
1984年 | 51篇 |
1983年 | 59篇 |
1982年 | 32篇 |
1981年 | 46篇 |
1980年 | 37篇 |
1979年 | 54篇 |
1978年 | 40篇 |
1977年 | 35篇 |
1926年 | 38篇 |
1925年 | 31篇 |
1924年 | 42篇 |
排序方式: 共有10000条查询结果,搜索用时 62 毫秒
1.
2.
3.
4.
5.
6.
7.
Prof. Dr. Wolfgang Dörr Sabine Köst Klaus Keinert Felix-Herbert Glaser Gerd Endert Thomas Herrmann 《Strahlentherapie und Onkologie》2006,182(1):1-8
PURPOSE: To compare tests for intestinal function with clinical scores after abdominal irradiation. PATIENTS AND METHODS: At the Department of Radiotherapy, Erfurt, Germany, intestinal changes were studied in 91 patients receiving abdominal radiotherapy between 1992 and 1996. Conventional fractionation (1.8-2 Gy per fraction, total doses 30.6-62.5 Gy) was applied. Before and at weekly intervals during radiotherapy, the clinical response was scored according to RTOG/EORTC for the upper and lower gastrointestinal (GI) tract. Resorption tests for vitamin B(12) and D-xylose were performed before the onset and immediately after treatment. RESULTS: The clinical response displayed a well-defined dose-effect relationship with grade 1 effects in 5% and 50% of the patients at about 10 Gy and 50 Gy, respectively. For grade 2 reactions, 5%- and 50%-effective doses were 20-30 Gy and 60-80 Gy. Effects in the upper and lower GI tract were highly correlated. Changes in body weight did not show a correlation with other clinical symptoms. Changes in resorption also displayed a significant dose effect. However, no correlation was found with the clinical symptoms in the individual patient. CONCLUSION: In the present study, the clinical manifestation of intestinal side effects according to RTOG/EORTC criteria was reflected by neither the vitamin B(12) nor by the D-xylose resorption test. Hence, these tests cannot be regarded as useful for objective quantitation of intestinal radiation injury. 相似文献
8.
Introduction
Planning human resources for health (HRH) is a complex process for policy-makers and, as a result, many countries worldwide swing from surplus to shortage. In-depth case studies can help appraising the challenges encountered and the solutions implemented. This paper has two objectives: to identify the key challenges in HRH planning in Belgium and to formulate recommendations for an effective HRH planning, on the basis of the Belgian case study and lessons drawn from an international benchmarking. 相似文献9.
Seppo W. Langer 《Current oncology reports》2010,12(4):242-246
Extravasation of chemotherapy is a feared complication of anticancer therapy. The accidental leakage of cytostatic agents
into the perivascular tissues may have devastating short-term and long-term consequences for patients. In recent years, the
increased focus on chemotherapy extravasation has led to the development of international guidelines that have proven useful
tools in daily clinical practice. Moreover, the tissue destruction in one of the most dreaded types of extravasation (ie,
anthracycline extravasation) now can effectively be prevented with a specific antidote, dexrazoxane. 相似文献
10.
Tariquidar-induced P-glycoprotein inhibition at the rat blood-brain barrier studied with (R)-11C-verapamil and PET. 总被引:1,自引:0,他引:1
Jens P Bankstahl Claudia Kuntner Aiman Abrahim Rudolf Karch Johann Stanek Thomas Wanek Wolfgang Wadsak Kurt Kletter Markus Müller Wolfgang L?scher Oliver Langer 《Journal of nuclear medicine》2008,49(8):1328-1335
The multidrug efflux transporter P-glycoprotein (P-gp) is expressed in high concentrations at the blood-brain barrier (BBB) and is believed to be implicated in resistance to central nervous system drugs. We used small-animal PET and (R)-11C-verapamil together with tariquidar, a new-generation P-gp modulator, to study the functional activity of P-gp at the BBB of rats. To enable a comparison with human PET data, we performed kinetic modeling to estimate the rate constants of radiotracer transport across the rat BBB. METHODS: A group of 7 Wistar Unilever rats underwent paired (R)-11C-verapamil PET scans at an interval of 3 h: 1 baseline scan and 1 scan after intravenous injection of tariquidar (15 mg/kg, n = 5) or vehicle (n = 2). RESULTS: After tariquidar administration, the distribution volume (DV) of (R)-11C-verapamil was 12-fold higher than baseline (3.68 +/- 0.81 vs. 0.30 +/- 0.08; P = 0.0007, paired t test), whereas the DVs were essentially the same when only vehicle was administered. The increase in DV could be attributed mainly to an increased influx rate constant (K1) of (R)-11C-verapamil into the brain, which was about 8-fold higher after tariquidar. A dose-response assessment with tariquidar provided an estimated half-maximum effect dose of 8.4 +/- 9.5 mg/kg. CONCLUSION: Our data demonstrate that (R)-11C-verapamil PET combined with tariquidar administration is a promising approach to measure P-gp function at the BBB. 相似文献